Cutaneous sporotrichosis treated with photodynamic therapy: An in vitro and in vivo study

  • Yolanda Gilaberte
  • , Carmen Aspiroz
  • , M. Carmen Alejandre
  • , Elena Andres-Ciriano
  • , Blanca Fortuño
  • , Luis Charlez
  • , Maria Jose Revillo
  • , Michael R. Hamblin
  • , Antonio Rezusta

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)

Abstract

Background: Sporotrichosis is a fungal infection caused by Sporothrix schenckii complex, usually restricted to the skin, subcutaneous cellular tissue, and adjacent lymphatic vessels. Antimicrobial photodynamic therapy (aPDT) could be a good alternative to manage localized, superficial infections. Case report: A 65-year-old African woman was diagnosed with a fixed cutaneous sporotrichosis on her left arm, treated with itraconazol and oral terbinafine with partial improvement. Topical 16% methyl aminolevulinate (MAL, Metvix®)- PDT was used without success. Methods: An in vitro photoinactivation test with the isolated microorganism revealed phenothiazinium salts to be more effective than MAL. Conclusions: PDT with intralesional 1% methylene blue (MB) in combination with intermittent low doses of itraconazole obtained complete microbiological and clinical response.

Original languageEnglish
Pages (from-to)54-57
Number of pages4
JournalPhotomedicine and Laser Surgery
Volume32
Issue number1
DOIs
Publication statusPublished - 2014
Externally publishedYes

ASJC Scopus subject areas

  • Biomedical Engineering
  • Radiology, Nuclear Medicine and Imaging

Fingerprint

Dive into the research topics of 'Cutaneous sporotrichosis treated with photodynamic therapy: An in vitro and in vivo study'. Together they form a unique fingerprint.

Cite this